The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
CA 2500577 C · Owner: Dinarello, Charles A. · Inventors: Kim, Soo-Hyun; Dinarello, Charles A.; Bufler, Philip
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of a cytokine-1 preferably from the , IL-1 family more preferably IL-1F7b or an isoform, mutein, fused protein, functional derivative or fragment thereof capable of binding to IL-18 BP or a , mutein fused protein, functional derivative or fragment thereof and capable of inhibiting a receptor of a cytokine-2 cytokine-2 being a member of the IL-, 1 family preferably IL-18, in the manufacture of a medicament for the treatment or prevention of a disease which is caused or aggravated by inducing said receptor of cytokine-2.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2003 and granted December 17, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.